Wednesday, February 23, 2011
Field Application Specialist Cell Based Assays, Immunoassays
* Support of field sales organization.
* Assist in selling assays kits and instrumentation.
* Assist customers with training and support.
* Assist customers with assay development in areas such as toxicology, PK, bio-production, neuroscience, inflammation, oncology, metabolic disorders, and immunogenicity.
1) Washington, DC Metro, Maryland area based candidate to cover Mid-Atlantic/Southeast territory.
2) New Jersey, eastern Pennsylvania
Looking for candidates with:
" BS, MS or PhD in biological sciences [MS or PhD preferred]
" Three plus years of immunoassay research experience [ELISA, antibodies, cytokines, biomarkers, etc.]
" Assay development experience a plus
" Product development experience preferred
" FAS or customer interface experience preferred
" Must have excellent communication skills
" Good relationship building skills
" Experience presenting seminars
" Good driving record
" Ability to travel overnight for business as needed [typical 30-50% depending on territory]
This position if for a highly motivated individual who can work well in a field based setting.
Compensation: Base salary $60-85K Base depending on experience,
commission/bonus $20-30K, car allowance, expenses, excellent benefits.
Time frame: Immediate.
For more info and how to apply:
Olga I. Shamraj, Ph.D.
Life Science Search Solutions, Inc.
2013 Crompond Rd.
Yorktown Heights, NY 10598
Postdoctoral Fellowship in Technology, Entertainment and Media, Fuqua School of Business
The Center for Technology, Entertainment and Media (CTEM) at Duke University’s Fuqua
School of Business invites applications for a post-doctoral fellowship to begin Fall 2011 for applicants whose research lies at the intersection of information technology, media, and business.
Preference will be given to applicants studying the social and organizational context of
computer-enabled information technologies (e.g., storage, networks, databases), communication technologies (e.g., mobile phones, Instant Messaging, Web conferencing), digital media (e.g., songs, shows, videos), social media (e.g., Facebook, MySpace, Twitter), or other emerging collaborative technologies (e.g., Google Docs, Skype, Second Life).
The Center for Technology, Entertainment and Media focuses on issues critical to firms in the IT industry (e.g., Google, IBM, Intel, Apple) and the Entertainment/Media industry (e.g., Time Warner, Disney, News Corp, Viacom) as well as the consequences of Technology and Entertainment/Media development and use for employees, firms, industries, and society. For example, business could benefit from greater knowledge about a media industry disrupted by digital technologies that are shifting how music, television, and films are viewed and distributed.
Business could also benefit from greater knowledge about tools being developed by firms in the IT industry to facilitate virtual organizations in which individuals and teams can work from any place at any time through information and communication technologies.
The Fuqua School of Business provides an outstanding environment for research, and topics related to technology and media are studied across Duke University, such as in computer science, information studies and information science, and sociology. The post-doctoral fellow will be expected to establish a research program and contribute to the intellectual environment of the Fuqua School of Business. He or she would work closely with Professor Jonathon Cummings (Faculty Director) and Professor Tony O’Driscoll (Executive Director), and other collaborations with faculty at Fuqua and at Duke will be encouraged. The salary is $65,000/year plus benefits.
- To apply:
Successful candidates must have a Ph.D. by August 2011. The post-doctoral fellowship is exclusively for recent Ph.D. graduates. Eligible candidates must not have previously held a faculty or postdoctoral position.
Applicants should submit a curriculum vitae, a brief summary of past and current research, and a statement of proposed research to Emily Xavier (email@example.com), Faculty Affairs Personnel Coordinator. Candidates should include the names and contact information for three individuals who would be willing to provide letters of recommendation. The candidate’s advisor will be asked to verify the date of Ph.D. completion. Applications received by April 1, 2011 will receive full consideration.
Duke University is an Equal Opportunity/Affirmative Action Employer committed to increasing the diversity of its employees. We strongly encourage applications from women and underrepresented minority candidates.
Grand Challenges: Biomarkers Grant Opportunity
The Bill & Melinda Gates Foundation is now accepting letters of inquiry for the new grant program Biomarkers for the Diagnosis of Tuberculosis.
This grant program is part of the Grand Challenges in Global Health initiative, whose purpose is to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. With up to $12 million of funding, the new program seeks to validate biomarkers for use in developing a low cost, simple to use test that can quickly and accurately diagnose tuberculosis in low-resource settings. The term biomarker is intended to include all types of markers that have potential utility for tuberculosis diagnosis and can include markers associated with either host or pathogen biology.
A letter of inquiry should be submitted no later than March 31, 2011. For more information about this grant opportunity and how to apply, please see the Rules and Guidelines, Frequently Asked Questions, and Application Instructions links.
Wednesday, February 16, 2011
International Doctoral/Postdoctoral Program in France
Applicants are asked to choose only one project from the ones proposed. 5 teams of the Institute propose one project. The scientific advisory board of the institute will select up to three candidates that will be interviewed on site for final selection.
DEADLINE FOR APPLICATION: May 1st, 2011.
Applicants must have completed their Ph.D. or M.D. between 2006 and Sept 2011. The application should be sent electronically to Valerie.Pecqueret@univ-nantes.fr and should include:
* a cover letter with a short description of achievements
* the chosen project and the reasons why the candidate applies to this program
* a short statement on career planning
* a CV with a complete list of publications and abstracts to international meetings
Moreover, two letters of reference should be sent before application deadline to Valerie.Pecqueret@univ-nantes.fr, with the name of the candidate in the e-mail subject.
Pre-selected candidates will be informed by June 1st, 2011. Final selection will be in September 2011 after interviews.
The Progreffe program is highly competitive and only up to three pre-selected candidates will be invited to present their past research and meet the research teams. The successful candidate will receive a letter of acceptance and a contract offer. The position can begin at any time after notification, but no later than 6 months after receiving the contract offer.
Team 1: Role of Langerin+ cells in a mucosal model of primary MCMV infection.
Team 2 : Role of Aire in the generation and function of CD8 regulatory T cells.
Team 4: Mechanisms and induction of liver tolerance in allotransplantation.
Team 5: Identification of seric factors involved in idiopathic nephrotic syndrome.
Team 6: Neuroimmune signaling in neuron survival and axonal outgrowth.
WEBS: Symposium for Early Career Female Biologists
WEBS targets early career women in the Biological Sciences with an emphasis on ecology and evolutionary biology. In particular, it focuses on women who have earned their doctoral degrees within the past two to eight years and who do not have tenure, in order to address the critical transition period from graduate studies and post-doctoral positions to permanent research and teaching positions. The symposium will provide a forum for professional development, including awareness and improvement of academic leadership skills; opportunities to establish mentoring relationships; and resources for developing professional networks. The 2011 symposium will be held at NESCent (National Evolutionary Synthesis Center) in Durham, NC, November 6-9, 2011.
Application Process Information
A complete application includes four online components and two email components:
- To be completed online:
- one-page (approx. 500 words) statement describing the applicant’s expectations for WEBS and how attending will aid her short and long-term career goals
- one page (approx. 500 words) statement explaining her research and teaching program and interests
- A mandatory online questionnaire. This survey will provide information about personal experiences and expectations of the WEBS symposium. (Estimated completion time: 30 minutes)
- A research information statement. WEBS attendees will be asked to share information from their application, complete a survey at the WEBS symposium, and take two follow-up surveys six- and eighteen-months after the symposium. Participation in the research is voluntary. Applicants are not obligated to participate and the decision not to participate will not preclude an applicant from being selected as a participant in the symposium.
- To be submitted via email to firstname.lastname@example.org :
- two-page Curriculum Vitae
- two letters of recommendation
We strongly advise applicants prepare the two personal statements (parts 1 and 2 of the online materials) BEFORE beginning the online application process. It will be possible to cut and paste the statement texts into the online form.
Sunday, February 6, 2011
Postdoctoral Fellowship Opportunities at Duke University
Program Rationale and Description
The CECD program is designed for talented basic/experimental researchers interested in multi-disciplinary research. The program aims to connect these researchers with essential knowledge and skills from cancer epidemiology, biostatistics, population genetics, and demography, placing an emphasis on how this knowledge can be integrated in the study of cancer etiology and outcomes leading to improved prevention and control measures through the synergism of bench and population sciences. The goal of this training program is to increase the pool of cancer researchers educated in the new scientific paradigms that require collaborations with researchers in disparate disciplines.
The fellowships are designed for three years and will include: l) didactic learning, 2) weekly seminars emphasizing connections between cancer biology, epidemiology, and demography; 3) research training and an applied project in population science of cancer involving the integrative approaches; 4) preparing scientific publications and a research grant application with interdisciplinary focus. The program will be based at the DCCC’s Research Program in Cancer Prevention, Detection, and Control, and will engage faculty, mentors, and Advisory Committee members from Duke Population Research Institute (DuPRI), Center for Population Health and Aging and other Duke Departments.
This program includes a core curriculum which consists of two parts: 1) courses taught through the Clinical Research Training Program (CRTP) and 2) seminars and courses taught by CECD faculty, which are tailored to the program.
All candidates are required to be involved with a research project. They are also encouraged to develop their own project that utilizes the data and biological samples available from ongoing epidemiologic studies at Duke University.
Candidates must have a PhD or equivalent and be engaged in cancer research. Candidates should have completed doctorate level training in basic or experimental cancer biology, pharmacology, genetics or related disciplines.
The candidate should send a letter describing his/her research interests (three-page maximum) and a copy of his/her Curriculum Vitae by e-mail to Sydnee Crankshaw (email@example.com). The candidate also should provide three names and contact information of individuals familiar with his/her research and academic potential. We will also be requesting three (3) letters of recommendation.
The program will award two fellowships in 2011 for three years of support commensurate on experience according to NIH guidelines. The deadline for receiving all candidate materials is March 1, 2011, with final placement of the two candidates by April 15, 2011. Anticipated start date for candidates is August 15, 2011.
The Irvington Institute Postdoctoral Fellowship Program
The Irvington Institute Fellowship Program of the Cancer Research Institute, formerly the Cancer Research Institute Postdoctoral Fellowship Program, answers the need for more researchers in the field of cancer immunology. It supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology or general immunology.
A panel of 23 scientists drawn from our Scientific Advisory Council rigorously evaluates each candidate, the intended sponsor and training environment, and the nature and feasibility of the proposed project.
- Applicants for the CRI Fellowship Program must be working in cancer immunology or general immunology. Proposals must aim to increase our understanding of the human immune system. Proposals outside the area of immunology WILL NOT be considered.
- Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
- Applicants with 5 or more years of relevant postdoctoral experience are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
- Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.
- Work can be carried out in the United States or abroad but must take place at non-profit institutions.
- Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.
The fellowship provides stipends of $45,000 for the first year, $47,000 for the second year and $49,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings or health insurance. Stipends and institutional allowances are not permitted to cover administrative expenses. Payments are made monthly in U.S. currency to the host institution.
Applications must be received by April 1 and October 1 annually; when those dates fall on the weekend, applications are accepted until the following Monday. Applicants are notified of fellowship decisions within approximately 10 weeks of the application deadline.
Fellowships can be activated three months after the application deadline but no later than one year of the deadline. Awards activate on the first of the month.
Applications are accepted in electronic format only. The application process requires you to download a PDF application form for institutional signature and certification. You must also submit an electronic application to CRI, during which you will be asked to upload supporting materials.
Also, CRI now designates at least two fellowship awards per round for projects with high relevance to cancer immunology. Applicants must indicate whether they wish to be considered for one of these cancer immunology postdoctoral fellowships and, if so, must provide a description of the relevance of their proposed project to cancer immunology. Applications that are not selected for a cancer immunology postdoctoral fellowship will be placed among the general application pool for consideration.
The next application deadline is April 1, 2011.
Saturday, February 5, 2011
Most Beautiful Girl in the Lab
Friday, February 4, 2011
FDA Medical Device Laboratory: Biomedical, Mechanical or Chemical Engineer Wanted for Polymer Studies
Qualifications: We seek an MS- or a PhD- level biomedical, mechanical, chemical or other engineer with a talent for adapting small fine motorized setups linked to optical data acquisition systems and an interest in biological, medically used, or other soft polymers. Candidate must be extremely organized, programming- and software-literate, and have excellent communication skills. Fine motor dexterity is important; you would be making and manipulating small amounts of delicate materials, as well as creating model interfaces. Training will be provided as necessary; candidates who can ramp up quickly and work independently are strongly preferred. This is a hands-on position.
This is not an academic or GS position; it is an ORISE Fellowship (1-year renewable) with the FDA's Center for Devices and Radiological Health Office of Science and Engineering laboratories (OSEL). We are located in Silver Spring, MD, just outside of Washington DC.
Deadline: 10 February 2011. US Citizenship not a requirement, but we do not sponsor work visas.
How to Apply:
We are currently accepting applications. To apply please send your CV to the following two addresses:
Katherine Vorvolakos, Ph.D.
FDA-OSEL Division of Chemistry and Material Science
Science Accounts Hit Hard by Planned House Budget Cuts
Today, House of Representatives Republicans unveiled a long-awaited plan to reduce federal spending this year that includes double-digit cuts in the panels that fund most of civilian basic research. It is $74 billion lower than President Barack Obama's 2011 request, submitted 1 year ago and never enacted, and is divided between $56 billion in civilian spending and $18 billion for security expenditures, including $9 billion from the military.
The spending plan comes in the form of an allocation to each of the 12 appropriations subcommittees that dole out the $3.4 trillion federal budget. The panel that controls the budgets of the National Science Foundation, NASA, and the Department of Commerce would get 16% less money than in 2010 and 11% less than President Obama has requested for the current, 2011 fiscal year. The panel that oversees the Department of Energy would receive 10% less than in 2010 and 15% less than the president's request. The panel that oversees the National Institutes of Health and the Education Department would receive 8% less than the president's request and 4% less than in 2010. However, the plan does not specify spending levels for individual agencies, which are currently being funded at 2010 levels in a continuing resolution (CR) that expires on 4 March.
These so-called 302b allocations, announced by the House Appropriations Committee, are expected to be voted on by the full House the week of 14 February. The goal is final passage by Congress before the CR expires. Not coincidentally, Obama submits his 2012 budget request to Congress on 14 February.on 3 February 2011 from science.com
Pfizer's Plan to Cut R&D Spending
Pfizer, the world's largest drug company, and one that's proud of its scientific acumen, announced yesterday that it will cut R&D spending in 2012 by about 20%, from $8.5 billion to $7 billion. The company also said that it will close a research facility in Sandwich, U.K., that employs a staff of about 2400 and sharply trim its U.S. research center in Groton, Connecticut (eliminating about 1100 jobs). At the same time, Pfizer plans to increase its research staff in Cambridge, Massachusetts, by several hundred, according to unofficial estimates. The aim, CEO Ian Read said in a teleconference with investors, will be to "fix our innovative core." Read, who took over in a rapid change at the helm in December, said he hopes to instill an "entrepreneurial sense" and a "results-oriented culture in research."
Before the announcement, Pfizer's stock price had been drifting downward because it faces business challenges. The company is losing exclusive control of several important drugs--including, this year, its U.S. rights to Lipitor, a key product. At the same time, new drugs have been slow to emerge from research labs, even after Pfizer's efforts to beef up its pipeline following a takeover of Wyeth in 2009. Pfizer's shakeup is intended to streamline the organization and focus on products that will give "consistent returns" in the market, Read said.
The reorganization will cut expenditures. To help boost stock value, Pfizer has set aside $5 billion to buy some of its own shares.
Some U.K. government and research leaders were shaken by Pfizer's announcement. The BBC reported that Colin Blakemore, a University of Oxford neuroscientist and former head of Britain's Medical Research Council, viewed Pfizer's decision as a "shocking wake-up call." He interpreted it as a "signal that one of our most important industries no longer has confidence in the future of British science." But Pfizer officials hastened to deny it. "Sandwich has an extremely talented workforce with a proud and rich history in science research and development. This decision is no reflection on the site, the workforce, or the operating environment in the U.K.," said Pfizer's chief at Sandwich, Ruth McKernan.
Subscribe to Posts [Atom]